K

Kora Saude Participacoes SA
BOVESPA:KRSA3

Watchlist Manager
Kora Saude Participacoes SA
BOVESPA:KRSA3
Watchlist
Price: 8.21 BRL -0.12% Market Closed
Market Cap: 634.9m BRL
Have any thoughts about
Kora Saude Participacoes SA?
Write Note
Section:
 

Relative Value

The Relative Value of one KRSA3 stock under the Base Case scenario is 105.25 BRL. Compared to the current market price of 8.21 BRL, Kora Saude Participacoes SA is Undervalued by 92%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

KRSA3 Relative Value
Base Case
105.25 BRL
Undervaluation 92%
Relative Value
Price
K
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
83
vs Industry
87
Median 3Y
3.7
Median 5Y
3.8
Industry
2.3
Forward
0.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-45.4
Median 5Y
-41.1
Industry
23.2
Forward
-13.2
More Details
9.8
P/OCF
P/OCF
Price to OCF
9.8
vs History
23
vs Industry
51
Median 3Y
-29.9
Median 5Y
-2.1
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.5
Industry
20.1
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
80
vs Industry
75
Median 3Y
8
Median 5Y
8.1
Industry
2.2
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
85
vs Industry
62
Median 3Y
4.7
Median 5Y
4.7
Industry
2.4
Forward
1.1
More Details
4.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.9
vs History
83
vs Industry
37
Median 3Y
21.1
Median 5Y
21.5
Industry
5
More Details
5.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.3
vs History
80
vs Industry
44
Median 3Y
24.9
Median 5Y
25.3
Industry
12.8
Forward
5.1
More Details
7.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
7.6
vs History
80
vs Industry
39
Median 3Y
40
Median 5Y
40
Industry
17.2
Forward
7.7
More Details
43.5
EV/OCF
EV/OCF
Enterprise Value to OCF
43.5
vs History
16
vs Industry
28
Median 3Y
-39.1
Median 5Y
-7.3
Industry
14
More Details
1 261.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
1 261.3
vs History
4
vs Industry
19
Median 3Y
-31.1
Median 5Y
-30.9
Industry
18.2
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
85
vs Industry
70
Median 3Y
2.5
Median 5Y
2.5
Industry
1.9
More Details

Multiples Across Competitors

KRSA3 Competitors Multiples
Kora Saude Participacoes SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Kora Saude Participacoes SA
BOVESPA:KRSA3
631.4m BRL 0.2 -5.3 5.3 7.6
US
HCA Healthcare Inc
NYSE:HCA
78.1B USD 1.1 13.2 8.3 10.8
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
23.8B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
19.8B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
128.4B CNY 6.2 35.4 26.7 26.7
MY
IHH Healthcare Bhd
KLSE:IHH
63.7B MYR 2.7 24 13 18.7
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.3 103.9 72.1 85.9
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.5 41.9 57.3
US
Tenet Healthcare Corp
NYSE:THC
12.2B USD 0.6 3.9 5.2 6.5
US
Universal Health Services Inc
NYSE:UHS
11.9B USD 0.8 11.6 7.7 10.7

See Also

Summary
KRSA3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
KRSA3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
KRSA3 stock valuation using valuation multiples.
Wall Street Estimates
KRSA3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
KRSA3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.